Rocket Pharmaceuticals (NASDAQ: RCKT) revenue
Rocket Pharmaceuticals reported revenue of $0.0m for fiscal 2025; in fiscal 2024 it was $0.0m.
Fiscal 2025 is the highest of the 10 fiscal years on record for Rocket Pharmaceuticals.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $0.0m | — | −$231.7m | — |
| 2024 | $0.0m | — | −$273.2m | — |
| 2023 | $0.0m | — | −$259.7m | — |
| 2022 | $0.0m | — | −$224.3m | — |
| 2021 | $0.0m | — | −$167.2m | — |
| 2020 | $0.0m | — | −$134.3m | — |
| 2019 | $0.0m | — | −$76.2m | — |
| 2018 | $0.0m | — | −$71.2m | — |
| 2017 | $0.0m | — | −$19.8m | — |
| 2016 | $0.0m | — | −$7.6m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Rocket Pharmaceuticals revenue compared with its sector
By revenue for its latest fiscal year, Rocket Pharmaceuticals ranks 415th of the 422 US health care companies with a page on Celsmar.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 413th | Palisade Bio | $0.0m | — |
| 414th | Praxis Precision Medicines | $0.0m | −100.0% |
| 415th | Rocket Pharmaceuticals | $0.0m | — |
| 416th | Revolution Medicines | $0.0m | — |
| 417th | SAB Biotherapeutics | $0.0m | −100.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Rocket Pharmaceuticals
- How much revenue did Rocket Pharmaceuticals make in fiscal 2025?
- Rocket Pharmaceuticals reported revenue of $0.0m for fiscal 2025, compared with $0.0m in fiscal 2024.
- What was the best year for revenue at Rocket Pharmaceuticals?
- Of its last 10 fiscal years, fiscal 2025, with $0.0m.
- Where does Rocket Pharmaceuticals rank in its sector by revenue?
- It ranks 415th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Rocket Pharmaceuticals come from?
- From the annual report (Form 10-K) that Rocket Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Rocket Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Rocket Pharmaceuticals: the Rocket Pharmaceuticals page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.